Patents by Inventor Philip Gordts

Philip Gordts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201228
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: February 17, 2023
    Publication date: June 29, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20230181609
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: February 9, 2023
    Publication date: June 15, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20230149433
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: January 23, 2023
    Publication date: May 18, 2023
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20220143056
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode
  • Patent number: 11234992
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: February 1, 2022
    Assignee: The Regents of the University of California
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode
  • Publication number: 20210236527
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: August 5, 2021
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20210236526
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: August 5, 2021
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20200237793
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 30, 2020
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20200230161
    Abstract: The disclosure provides for immunomodulatory oligosaccharides, and uses thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Applicant: The Regents of the University of California
    Inventors: Lars Bode, Philip Gordts
  • Publication number: 20190269713
    Abstract: The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
    Type: Application
    Filed: February 28, 2019
    Publication date: September 5, 2019
    Inventors: Philip Gordts, Ariane Pessentheiner, Lars Bode